Quantum redactiones paginae "L-Aminoacidorum aromaticorum decarboxylasis" differant
Content deleted Content added
mNo edit summary |
m anat. corr. |
||
Linea 2:
'''L-Aminoacidorum aromaticorum decarboxylasis''' (abbreviaturae '''AAAD''' et '''AADC''') sive '''DOPA decarboxylasis''' ('''DDC''') ([[numerus commissionis enzymorum|Numerus EC]]: [https://enzyme.expasy.org/EC/4.1.1.28 4.1.1.28]) est [[enzymum]], quod quasdam reactiones biochemicas celebrat. De functione AADC hae est [[lyasis|lyasium]] et effectus suus est [[decarboxylatio]] (eripere gregem carboxylici R–COOH, dein liberare [[carbonii dioxidum]] CO<sub>2</sub>. Nomen [[genum|geni]] ''DDC'' scribitur et genum in hominibus [[chromosoma 7 (homo)|chromosomate septimo]] invenitur<ref>{{cite journal |authors=Scherer LJ, McPherson JD, Wasmuth JJ, Marsh JL |title=Human dopa decarboxylase: localization to human chromosome 7p11 and characterization of hepatic cDNAs |journal=Genomics |year=1992 |volume=13 |issue=2 |pages=469-71 |url=https://www.ncbi.nlm.nih.gov/pubmed/1612608}}</ref>.
In [[Cerebrum|cerebro]] humano AADC imprimis in [[
In [[pharmacologia]] inhibitio AADC momentum magnitudinis effectuum prolongatorum praecursoris L-dihydroxy-phenylalanini (L-DOPA) [[neurotransmissor]]ium, quod necesse tractationis [[Morbus Parkinson|morbi Parkinson]] est. In [[oncologia]] AADC cursum adenocarcinomatum stomachi indicare potest<ref>{{cite journal |authors=Florou D, Papadopoulos IN, Fragoulis EG, Scorilas A |title=L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas |journal=J Cancer Res Clin Oncol |year=2013 |volume=139 |issue=2 |pages=297-306 |url=https://www.ncbi.nlm.nih.gov/pubmed/23064786}}</ref>.
| |||